SHANGHAI – In China, it is often said there is more venture capital (VC) money sloshing around than there are good assets, or companies in which to invest. That poses an interesting conundrum for VCs: They see the sizable money-making potential in China – given the increasing market demands of a rapidly aging population with significant unmet medical needs – but face a lack of readymade investment vehicles to fund.